Literature DB >> 32409731

Longitudinal brain connectivity changes and clinical evolution in Parkinson's disease.

Massimo Filippi1,2,3, Silvia Basaia4, Elisabetta Sarasso4,5, Tanja Stojkovic6, Iva Stankovic6, Andrea Fontana7, Aleksandra Tomic6, Noemi Piramide4,5, Elka Stefanova6, Vladana Markovic6, Vladimir S Kostic6, Federica Agosta4,5.   

Abstract

Longitudinal connectivity studies might guide our understanding of the underlying neurodegenerative processes. We report the results of a longitudinal study in patients at different stages of Parkinson's disease (PD), who performed motor and non-motor evaluations and serial resting state (RS) functional MRI (fMRI). Cluster analysis was applied to demographic and clinical data of 146 PD patients to define disease subtypes. Brain network functional alterations were assessed at baseline in PD relative to 60 healthy controls and every year for a maximum of 4 years in PD groups. Progression of brain network changes were compared between patient clusters using RS fMRI. The contribution of network changes in predicting clinical deterioration was explored. Two main PD clusters were identified: mild PD (86 patients) and moderate-to-severe PD (60 patients), with the latter group being older and having earlier onset, longer PD duration, more severe motor, non-motor and cognitive deficits. Within the mild patient cluster, two clinical subtypes were further identified: mild motor-predominant (43) and mild-diffuse (43), with the latter being older and having more frequent non-motor symptoms. Longitudinal functional connectivity changes vary across patients in different disease stages with the coexistence of hypo- and hyper-connectivity in all subtypes. RS fMRI changes were associated with motor, cognitive and non-motor evolution in PD patients. Baseline RS fMRI presaged clinical and cognitive evolution. Our network perspective was able to define trajectories of functional architecture changes according to PD stages and prognosis. RS fMRI may be an early biomarker of PD motor and non-motor progression.
© 2020. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2020        PMID: 32409731     DOI: 10.1038/s41380-020-0770-0

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  6 in total

1.  Alterations in degree centrality and cognitive function in breast cancer patients after chemotherapy.

Authors:  Wensu Zhou; Weizhong Tian; Jianguo Xia; Yuan Li; Xiaolu Li; Tianyi Yao; Jingcheng Bi; Zhengcai Zhu
Journal:  Brain Imaging Behav       Date:  2022-06-10       Impact factor: 3.224

Review 2.  Imaging the Functional Neuroanatomy of Parkinson's Disease: Clinical Applications and Future Directions.

Authors:  Fulvio Lauretani; Yari Longobucco; Giulia Ravazzoni; Elena Gallini; Marco Salvi; Marcello Maggio
Journal:  Int J Environ Res Public Health       Date:  2021-02-28       Impact factor: 3.390

3.  Antagonistic network signature of motor function in Parkinson's disease revealed by connectome-based predictive modeling.

Authors:  Xuyang Wang; Kwangsun Yoo; Huafu Chen; Ting Zou; Hongyu Wang; Qing Gao; Li Meng; Xiaofei Hu; Rong Li
Journal:  NPJ Parkinsons Dis       Date:  2022-04-22

4.  Modulation of cortical resting state functional connectivity during a visuospatial attention task in Parkinson's disease.

Authors:  Dániel Veréb; Márton Attila Kovács; Szabolcs Antal; Krisztián Kocsis; Nikoletta Szabó; Bálint Kincses; Bence Bozsik; Péter Faragó; Eszter Tóth; András Király; Péter Klivényi; Dénes Zádori; Zsigmond Tamás Kincses
Journal:  Front Neurol       Date:  2022-08-09       Impact factor: 4.086

5.  Cerebro-cerebellar motor networks in clinical subtypes of Parkinson's disease.

Authors:  Silvia Basaia; Federica Agosta; Alessandro Francia; Camilla Cividini; Roberta Balestrino; Tanja Stojkovic; Iva Stankovic; Vladana Markovic; Elisabetta Sarasso; Andrea Gardoni; Rosita De Micco; Luigi Albano; Elka Stefanova; Vladimir S Kostic; Massimo Filippi
Journal:  NPJ Parkinsons Dis       Date:  2022-09-06

6.  Progressive brain atrophy and clinical evolution in Parkinson's disease.

Authors:  Massimo Filippi; Elisabetta Sarasso; Noemi Piramide; Tanja Stojkovic; Iva Stankovic; Silvia Basaia; Andrea Fontana; Aleksandra Tomic; Vladana Markovic; Elka Stefanova; Vladimir S Kostic; Federica Agosta
Journal:  Neuroimage Clin       Date:  2020-08-07       Impact factor: 4.881

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.